The synthesis, characterisation and in vivo study of a bioceramic for potential tissue regeneration applications

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Poinern, Gérrard Eddy Jai ^a   Brundavanam, Ravi Krishna ^a   Thi Le, Xuan ^a   Nicholls, Philip K ^a   Cake, Martin A ^a   Fawcett, Derek ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE PROSTHESIS; CERAMICS; HYDROXYAPATITE;

ANIMAL; BONE PROSTHESIS; BONE REGENERATION; CERAMICS; CHEMISTRY; DOMESTIC SHEEP; IMPLANT; PARTICLE SIZE; POROSITY; POWDER DIFFRACTION; REGENERATIVE MEDICINE; TISSUE SCAFFOLD; X RAY DIFFRACTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BONE SUBSTITUTES; CERAMICS; DURAPATITE; IMPLANTS, EXPERIMENTAL; PARTICLE SIZE; POROSITY; POWDER DIFFRACTION; REGENERATIVE MEDICINE; SHEEP, DOMESTIC; TISSUE SCAFFOLDS; X-RAY DIFFRACTION;

EID: 84906815270     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06235     Document Type: Article

References (56)

1. Kao, S. T.&Scott, D. D.AReview of Bone Substitutes. Oral. Maxillofac. Surg. Clin. North Am. 19, 513-521 (2007).
2. Brems, J. J. Role of bone graft substitutes for glenoid bone defects. J. Shoulder Elbow Surg. 16, S282-S285 (2007).
3. LaPrade, R. F. & Botker, J. C. Donor site morbidity after osteochondral autograft transfer procedures. Arthroscopy. 20, e69-e73 (2004).
4. Mischkowski, R. A. et al. Donor site morbidity of ear cartilage autographs. Plast. Reconstr. Surg. 121, 79-87 (2008).
5. Ng, V. Risk of disease transmission with bone allograft. Orthopaedics. 35, 679-681 (2012).
6. Veronese, F. M. et al. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, bio-distribution, and antitumor activity. Bioconjug. Chem. 16, 775-784 (2005).
7. Wong, H. L. et al. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm. Res. 23, 1574-1585 (2006).
8. Timmer, M. D., Shin, H. & Horch, R. A. In vitro cytotoxicity of injectable and biodegradable poly (propylene fumarate)-based networks: unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules. 4, 1026-1033 (2003).
9. Song, C. et al. Facilitation of hematopoietic recovery by bone grafts with intrabone marrow-bone marrow transplantation. Immunobiology. 213, 455-468 (2008).
10. Habibovic, P. et al. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials. 26, 3565-3575 (2005).
11. Ripamonti, U. [Smart biomaterials with intrinsic osteoinductivity: Geometric control of bone differentiation] In bone engineering [Davies, J. E. (ed.)] [215-222] (EM Squared Incorporation, Toronto, 2000).
12. Schindler, O. S. et al. Use of a novel bone graft substitute in peri-articular bone tumours of the knee. The Knee. 14, 458-464 (2007).
13. Murugan, R. & Ramakrishna, S. Development of nanocomposites for bone grafting. Comp. Sci. Technol. 65, 2385-2406 (2005).
14. Galois, I. & Mainard, D. Bone ingrowth into porous ceramics with different pore sizes: an experimental study. Acta. Orthop. Belg. 70, 598-603 (2004).
15. Hutmacher, D. W. et al. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J. Tissue. Eng. Regen. Med. 1, 245-260 (2007).
16. Habraken, W. J. E. M., Wolke, J. G. C. & Jansen, J. A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug. Deli. Rev. 59, 234-248 (2007).
17. Taniguchi, M. et al. The clinical application of intravenous catheter with percutaneous device made of sintered hydroxyapatite. Jpn. J. Artif. Organs. 20, 460-464 (1991).
18. Silva, R. V. et al. The use of hydroxyapatite and autogenous cancellous bone grafts to repair bone defects in rats. Inter. J. Oral & Maxillofacial Surg. 34, 178-184 (2005).
19. Stoch, A. et al. Sol-gel derived hydroxyapatite coatings on titanium and its alloy Ti6Al4V. J. Mol. Struct. 744, 633-640 (2005).
20. Kalita, S. J., Bhardwaj, A. & Bhatt, H. A. Nano-crystalline calcium phosphate ceramics in biomedical engineering. Mater. Sci. Eng. C. 27, 441-449 (2007).
21. Blom, A. Which scaffold for which application. Curr. Orthop. 21, 280-287 (2007).
22. Habibovic, P. & de Groot, K. Osteoinductive biomaterials-properties and relevance in bone repair. J. Tissue. Eng. Regen. Med. 1, 25-32 (2007).
23. Epple, M. et al. Application of calcium phosphate nanoparticles in biomedicine. J. Mater.Chem. 20, 18-23 (2010).
24. Hagmeyer, D. et al. Self-assembly of calcium phosphate nanoparticles into hollow spheres induced by dissolved amino acids. J. Mater. Chem. 21, 9219-9223 (2011).
25. Liao, C.-J. et al. Thermal decomposition and reconstitution of hydroxyapatite in air atmosphere. Biomaterials. 20, 1807-1813 (1999).
26. Danilchenko, S. N. et al. Determination of the bone mineral crystallite size and lattice strain from diffraction line broadening. Cryst. Res. Technol. 37, 1234-1240 (2002).
27. Klug, H. P. & Alexander, L. E. X-ray diffraction procedures for polycrystallite and amorphous materials (Wiley, New York, 1974).
28. Barrett, C. S. et al. Advances in X-ray analysis (Plenum Press, New York, 1986).
29. Landi, E. et al. Densification behaviour and mechanisms of synthetic hydroxyapatites. J. Eur. Ceramic. Soc. 20, 2377-2387 (2000).
30. Zhuo, Z.-H. et al. Controllable synthesis of hydroxyapatite nanocrystals via a dendrimer-assisted hydrothermal process. Materials Research Bulletin. 42, 1611-1618 (2007).
31. Aryal, S. et al. Synthesis and characterisation of hydroxyapatite using carbon nanotubes as a nano-matrix. Scripta Materialia. 54, 131-135 (2006).
32. Saeri, M. R. et al. The wet precipitation process of hydroxyapatite. Mater. Lett. 57, 4064-4069 (2003).
33. Afshar, A. et al. Some important factors in the wet precipitation process of hydroxyapatite. Materials and Design. 24, 197-202 (2003).
34. Bezzi, G. et al. Anovel sol-gel technique for hydroxyapatite preparation. Materials Chemistry and Physics. 78, 816-824 (2003).
35. Wang, Y. J. et al. Surfactant-assisted synthesis of hydroxyapatite particles. Mater. Lett. 60, 3227-3231 (2006).
36. Wang, Y. et al. Hydrothermal synthesis of hydroxyapatite nano-powders using cationic surfactant as a template. Mater. Lett. 60, 1484-1487 (2006).
37. Panda, R. N. et al. FTIR, XRD, SEM and solid state NMR investigations of carbonate-containing hydroxyapatite nano-particles synthesised by hydroxidegel technique. J. Physics and Chemistry of Solids. 64, 193-199 (2003).
38. Farzadi, A., Solati-Hashjin, M., Bakhshi, F. & Aminian, A. Synthesis and characterization of hydroxyapatite/b-tricalcium phosphate nano-composites using microwave irradiation. Ceramics International. 37, 65-71 (2011).
39. Bancroft, J. D. & Gamble, M. Theory and practice of histology techniques (Churchill Livingstone, London, 2002).
40. Junqueira, L. C. U. et al. Differential histological diagnosis of osteoid. Journal of Pathology. 148, 189-196 (1986).
41. Poinern, G. E. J. et al. Synthesis and characterisation of nanohydroxyapatite using an ultrasound assisted method. Ultrasonics Sonochemistry. 16, 469-474 (2009).
42. Poinern, G. E. J. et al. Thermal and ultrasonic influence in the formation of nanometre scale hydroxyapatite bio-ceramic. International Journal of Nanomedicine. 6, 2083-2095 (2011).
43. Dorozhkin, S. V. Medical application of calcium orthophosphate bioceramics. BIO. 1, 1-51 (2011).
44. Webster, T. J. et al. Enhanced osteoclast-like cell functions on nanophase ceramics. Biomaterials. 22, 1327-1333 (2001).
45. Detch, R. et al. The resorption of nanocrystalline calcium phosphates by osteoclast-like cells. Acta Biomater. 6, 3223-3233 (2010).
46. Koerten, H. & van der Meulen, J. Degradation of calcium phosphate ceramics. J. Biomed. Mater. Res. 44, 78-86 (1999).
47. Li, S. et al. The effects of sintering temperature and pressure on the sintering behaviour of hydroxyapatite powder prepared by spark plasma sintering. J. Biomech. Sci. Eng. 3, 1-12 (2008).
48. Despang, F. et al. Synthesis and physicochemical, in vitro and in vivo evaluation of an anisotropic, nanocrystalline hydroxyapatite bisque scaffold with parallelaligned pores mimicking themicrostructure of cortical bone. J. Tissue. Eng. Regen. Med. DOI:10.1002/term.1729 (2013).
49. Tadica, D. et al. A novel method to produce hydroxyapatite objects with interconnecting porosity that avoids sintering. Biomaterials. 25, 3335-3340 (2004).
50. Galois, L. & Mainard, D. Bone in growth into two porous ceramics with different pore sizes: an experimental study. Acta Orthop. Belg. 70, 598-603 (2004).
51. Cunningham, E. et al.High solid content hydroxyapatite slurry for the production of bone substitute scaffolds. Proc. IMechE. HJ. Eng. Med. 223, 727-737 (2009).
52. Landi, E. et al. Carbonated hydroxyapatite as bone substitute. J. Eur. Ceram. Soc. 23, 2911-2937 (2003).
53. Lonnissa, H. et al. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng Part B Rev. 18, 363-382 (2012).
54. Aichmair, A. et al. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion. The Spine Journal. 13, 1411; DOI: 10.1016/j.spine.2013.07.473 (2013).
55. Luo, X. et al. Zinc in calcium phosphate mediates bone induction: in vitro and in vivo model. Acta Biomateriala. 10, 477-485 (2014).
56. Poinern, G. E. J., Brundavanam, R. K., Le, X. & Fawcett, D. The mechanical properties of a porous ceramic derived from a 30 nmsized particles based powder of hydroxyapatite for potential hard tissue engineering applications. Am. J. Biomed. Eng. 2, 278-286 (2012).